Concepedia

Henry Pertinez

HP

27

Publications

1.1K

Citations

18

H-Index

2009

Active since

Affiliations

University of Liverpool(Current)

Liverpool School of Tropical Medicine

University of Manchester

University of Cambridge

Chelsea and Westminster Hospital NHS Foundation Trust

Henry Pertinez is an author at University of Liverpool specializing in medicine, pharmacology, and pharmacokinetics.

Top concepts

Publications per year

2009–2022

27

Publications

27

FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2

Teresa Brevini, Mailis Maes, Gwilym J. Webb et al. · Nature · 2022 · 282 citations · Full text

Simulation of Human Intravenous and Oral Pharmacokinetics of 21 Diverse Compounds Using Physiologically Based Pharmacokinetic Modelling

Hannah M. Jones, Iain Gardner, Wendy T. Collard et al. · Clinical Pharmacokinetics · 2011 · 111 citations

, , +10

Efficacy and Safety of High-Dose Rifampin in Pulmonary Tuberculosis. A Randomized Controlled Trial

Gustavo E. Velásquez, Meredith B. Brooks, Julia Coit et al. · American Journal of Respiratory and Critical Care Medicine · 2018 · 111 citations

Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled study

Saye Khoo, Richard J. Fitzgerald, Sean Ewings et al. · Journal of Antimicrobial Chemotherapy · 2021 · 111 citations · Full text

Dose prediction for repurposing nitazoxanide in SARS‐CoV‐2 treatment or chemoprophylaxis

Rajith K. R. Rajoli, Henry Pertinez, Usman Arshad et al. · British Journal of Clinical Pharmacology · 2020 · 56 citations · Full text

Rows per page

1–5 of 27